- Home
- GRAL
GRAL
GRAIL INC
as 12-20-2024 4:00pm EST
Stocks
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | MENLO PARK |
| Market Cap: | 610.9M | IPO Year: | N/A |
| Target Price: | $16.00 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -63.77 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.33 - $24.92 | Next Earning Date: | 02-15-2025 |
| Revenue: | $117,669,000 | Revenue Growth: | 111.83% |
| Revenue Growth (this year): | 32.48% | Revenue Growth (next year): | 14.72% |
Latest GRAIL INC News
GRAL Breaking Stock News: Dive into GRAL Ticker-Specific Updates for Smart Investing
PR Newswire
4 days ago
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Benzinga
6 days ago
What's Going On With Illumina Stock On Monday?
Investor's Business Daily
12 days ago
One Of IBD's Best Screens Identifies These Four Market Leaders, Including Garmin, Ollie's
PR Newswire
19 days ago
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
MT Newswires
a month ago
Grail 1st-Mover Advantage Faces Regulatory Hurdles in Multi-Cancer Detection, Morgan Stanley Says
MT Newswires
a month ago
Grail Insider Sold Shares Worth $426,937, According to a Recent SEC Filing
PR Newswire
a month ago
GRAIL to Participate in Upcoming Investor Conferences
MT Newswires
a month ago
GRAIL Says First Person Tested With Blood-Based Assay in Lung Cancer Trial
Compare GRAL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GRAL GRAIL INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.